The OnePlus Nord 4 is available for under Rs 25,000 during the Amazon Great Republic Day Sale, offering savings with bank ...

OnePlus Nord 4 is available for Rs 25,999 on Amazon with bank offers.. Know how the deal works to get the OnePlus Nord 4 at ...

Global food commodity prices declined by 2.1% in 2024 compared to the previous year, the United Nations food agency said on Friday, but they remain considerably higher than before the COVID-19 ...

OnePlus has already advertised the OnePlus 13 as IP68/IP69 ingress protection. For some past OnePlus hardware, IP ratings have varied across markets. With the OnePlus 13, though, the company ...

OnePlus Ace 5V may sport a 1.5K flat display with slim bezels The MediaTek Dimensity 9350 could be dubbed the Dimensity 9300++ The purported chipset is tipped to compete with Snapdragon 8s Elite SoC ...

This marks a slight increase from the OnePlus 12's launch price of Rs 64,999 for the base model. Global availability may include additional configurations to cater to a wider audience. The OnePlus 13 ...

UK house prices ended 2024 some 4.7% higher than at the start of the year, according to the Nationwide. Property prices and housing market activity remained "remarkably resilient" despite ...

It may also be launched internationally as the OnePlus Nord 5, according to GSMArena. What should we expect from a phone with a 7,000mAh battery? Expect this to be at least a two-day phone per ...

After the launch in China, OnePlus is gearing up for the global launch of its flagship OnePlus 13. Along with it, the OnePlus 13R will also make its debut. The smartphones will be launched in ...

For more financial news, go to the News24 Business front page. Rolex SA, the biggest luxury Swiss watch brand, raised prices on some of its most popular models after gold values surged in 2024. The ...

For context, the OnePlus 12 was launched at Rs 64,999, so this price hike is justified given the improvements in performance and design. The OnePlus 13 promises to be a significant upgrade, with ...

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer PFE.N COVID-19 treatment Paxlovid, Bristol Myers Squibb's BMY.N cancer cell therapies and vaccines ...